A genetics-led approach defines the drug target landscape of 30 immune-related traits
Most candidate drugs currently fail later-stage clinical trials, largely due to poor prediction of efficacy on early target selection1. Drug targets with genetic support are more likely to be therapeutically valid2,3, but the translational use of genome-scale data such as from genome-wide associat...
Main Authors: | Fang, H, De Wolf, H, Knezevic, B, Burnham, K, Osgood, J, Sanniti, A, Lledó Lara, A, Kasela, S, De Cesco, S, Wegner, J, Handunnetthi, L, McCann, F, Chen, L, Sekine, T, Brennan, P, Marsden, B, Damerell, D, O’Callaghan, C, Bountra, C, Bowness, P, Sundström, Y, Milani, L, Berg, L, Göhlmann, H, Peeters, P, Fairfax, B, Sundström, M, Knight, J |
---|---|
格式: | Journal article |
语言: | English |
出版: |
Springer Nature
2019
|
相似书籍
-
Genomic insights into myasthenia gravis identify distinct immunological mechanisms in early and late onset disease
由: Handunnetthi, L, et al.
出版: (2021) -
High-throughput structural characterisation of therapeutic protein targets.
由: Marsden, B, et al.
出版: (2006) -
High-throughput structural characterisation of therapeutic protein targets
由: Marsden, B, et al.
出版: (2006) -
Insights for the development of specific kinase inhibitors by targeted structural genomics.
由: Fedorov, O, et al.
出版: (2007) -
Science Forum: Donated chemical probes for open science
由: Müller, S, et al.
出版: (2018)